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Abstract
Many soluble factors of neural, endocrine, paracrine and
autocrine origin are present in the thymus and modulate
its function. Long-term effects of sex steroids have been
documented for thymocytes and cells of the thymic
microenvironment. In this report we examine rapid ac-
tions of progesterone upon aspects of epithelial cell
physiology. Progesterone (0.1–10 ÌM) was applied to
cultured thymulin-secreting thymic epithelial cells (TS-
TEC) and changes in transmembrane potential, trans-
membrane current, intracellular calcium levels and thy-
mulin secretion were assessed. Rapid changes in elec-
trophysiology and intracellular calcium provide evidence
for a membrane-bound progesterone receptor in these
cells, in addition to classical cytoplasmic receptors. Ap-
plication of progesterone to TS-TEC caused electrophysi-
ological changes in 56% of cells (n = 40), activating an
inward current (–24 B 9 pA at 1 ÌM, n = 7, p ! 0.02) and
dose-dependent depolarization (7.1 B 1.8 mV at 1 ÌM,
n = 19, p ! 0.01). Intracellular calcium levels, monitored
by the ratiometric fluorescent calcium indicator fura-2,
increased within seconds of progesterone (1 ÌM) appli-
cation. Progesterone (1 ÌM) increased thymulin levels in
supernatant, as measured by ELISA, above the levels in
the preapplication period (142 B 16% of the preapplica-
tion period, n = 3, p ! 0.02). This effect was reduced in the
presence of cobalt chloride which blocks voltage-depen-
dent calcium channels. In addition, TS-TEC in culture
were immunoreactive to antibody AG7. This antibody
was raised to a membrane-bound antigen involved in
calcium influx subsequent to progesterone binding in
sperm. Thus we suggest that progesterone acts upon
many aspects of TS-TEC physiology through both cyto-
plasmic and membrane-bound receptors.
Introduction
Many authors have shown that sex steroid levels alter
structure and function of the thymic microenvironment
[1–8]. Because of the complexity of steroid interactions
and catabolism, the effects of progesterone are not clear.
Although all of the sex steroids cause involution of the
thymus similar to that seen in pregnancy [reviewed in 9],
thymic involution at this time is correlated with serum
progesterone levels [10]. However, in general it appears
that for most parameters so far studied, oestrogens have a
greater effect than progesterone [11–14], appearing to
arrest thymocyte development at the earliest stage [15].
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Cytoplasmic receptors for progesterone and oestrogen
have been demonstrated in the thymus. Levels of cyto-
plasmic receptors for these hormones are much lower in
lymphoid cells of the thymus than in the stromal cells [16–
18]. Epithelial steroid receptors were found in the medul-
lary region, especially at the corticomedullary junction
with a few positive cells in the subcapsular area [18].
Some of these cells were thymulin immunopositive [19].
Synthesis of cytoplasmic progesterone receptors is in-
creased by oestrogens [17], decreased by progesterone [16,
20], and upregulated in pregnancy [21].
Classically, steroid receptors are considered to be local-
ized in the cytoplasm and to act in a genomic manner. As
early as 1942, Selye [4] noted immediate anaesthetic
effects of progesterone that are incompatible with a ge-
nomic action. However, such effects were slow to be rec-
ognized [22]. A clear example of this type of nongenomic
action has been supplied by the work on the acrosome
reaction whereby rapid direct action of progesterone at
the cell membrane initiates calcium influx and capaci-
tates sperm [23]. Membrane-bound progesterone recep-
tors have been recently identified in various cells [24–
26].
Within thymulin-secreting thymic epithelial cells (TS-
TEC), the genomic action of sex hormones via the nuclear
receptor complexes are indicated by studies that co-local-
ized sex hormone receptors and thymulin in TEC [19] and
reports showing long-term alterations in production and
expression of thymulin by sex hormone treatment [27].
Steroids also altered prostoglandin production by TEC
[28]. Nongenomic mechanisms have been suggested for
sex steroid-induced changes in TEC proliferation subse-
quent to alterations in protein kinase C levels [29].
In vitro studies of steroid action on thymic epithelial
cells demonstrated increased thymulin secretion from cul-
tures of rat and human TEC after long-term incubations
with progesterone, testosterone and 17ß-estradiol [27].
The steroids also increased the percentage of thymulin-
secreting cells in these cultures suggesting an effect on pro-
liferation. Long-term co-incubation with the progesterone
antagonist RU-486 abrogated the progesterone effect. Ste-
roid-induced increases in TS-TEC proliferation were con-
firmed by Head et al. [30] who also showed decreased
intercellular coupling in TS-TEC after incubations with
steroids.
This paper investigates rapid actions of progesterone
upon a range of physiological parameters of TS-TEC to
determine if nongenomic actions of progesterone are
present and to clarify that progesterone has direct actions
upon these thymic epithelial cells.
Materials and Methods
Cell Culture
Thymic epithelial cell cultures were produced, characterized and
passaged according to published methods [31]. Three culture media
(two with additions from Sigma) were used in the study. A basal
medium was used for cell equilibration comprising DMEM/F12
(Gibco) alone. A defined, serum-free medium was used for control
incubations, comprising DMEM/F12 plus the following additions:
2 ÌM l-glutamine, 100 U/ml penicillin/streptomycin and 25 g/ml
transferrin). The standard culture medium was used for routine cul-
ture of the cells, comprising the defined medium plus 10% horse
serum, 5 g/ml insulin, 10 ng/ml cholera toxin and epidermal growth
factor (100 ng/ml). All experiments were carried between passages
20–30 when the culture characteristics are stable [30].
Estimation of Thymulin in Supernatants
Cultured cells were equilibrated for 1 h in basal medium. They
were then incubated for 2 h each in the defined medium, or defined
medium plus either 1 ÌM progesterone, 2.5 mM cobalt chloride or
1 ÌM progesterone with 2.5 mM cobalt chloride. After this incuba-
tion the cells were returned to the defined medium. The experiment
was replicated 3 times. The supernatant from each incubation was
reserved and stored at –70°C before estimation of thymulin content
by ELISA as previously described [30]. Briefly, each supernatant
sample was mixed with an optimal dilution of primary antibody
RMK4 and allowed to equilibrate for 18 h at 4 °C. Free thymulin in
the sample bound excess antithymulin antibody in the liquid phase.
In the second step, 120 ml of each sample/RMK4 mixture was trans-
ferred to a high binding plate, previously coated with synthetic thy-
mulin, to which any remaining free antibody bound. Thus the
amount of free antibody that reacted in this step correlated inversely
with the thymulin concentration in the initial sample. The antibody
bound to the thymulin, and hence the plate, was reacted with peroxi-
dase-conjugated secondary antibodies, that catalysed colour develop-
ment of 3,3),5,5)-tetramethylbenzidine in the presence of H2O2.
Colour development was stopped by the addition of H2SO4 to pro-
duce a static endpoint, read as optical density at 450 nm on a spectro-
photometer and compared against a calibration curve (from the same
plate) of known concentrations of synthetic thymulin.
Electrophysiology
TEC cultures were grown in the standard medium in 35-mm dishes
for 3 days after passage. The cells were rounded up for recording by a
5-min incubation in enzyme-free dissociation fluid (Sigma) after
which they were equilibrated for 15 min in a modified Ringer’s solu-
tion containing 144 mM NaCl, 5.4 mM KCl, 1 mM MgCl, 2.5 mM
CaCl2, 5.6 mM D-glucose, 5 mM HEPES and 0.001% w/v phenol red.
Intercellular recording solutions contained 140 mM KCl, 5 mM NaCl,
0.5 mM CaCl2, 3 mM Mg-ATP, 5 mM EGTA and 10 mM HEPES.
During control and recovery periods the modified Ringer’s solution
was perfused across the surface of the cell through a gravity feed, Y-
tube assembly. Differing concentrations of progesterone (0.1, 1 and 10
ÌM ) were made up in modified Ringer’s solution and administered
through the perfusion apparatus which was quickly interchangeable
between control and test solutions. Recordings were made in whole cell
current clamp and voltage clamp at –100 mV to investigate the cur-
rents and membrane potential changes induced by progesterone.
Glass micropipette electrodes of resistance between 0.2 and 10 M
were applied to the cell at 400! magnification on an Olympus
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(IMT-2) inverting microscope under phase-contrast illumination.
Seals were formed by the application of suction through the micro-
electrode. Seals with resistance !1 Gø were discarded. Whole cell
current and voltage recordings were obtained using a RK400 patch-
clamp amplifier (Biologic). DC offsets resulting from junction poten-
tials were corrected. Errors due to series resistance and capacitance
were minimized using the compensation circuits of the amplifier.
Raw data was displayed on a Schlumberger Enertec 5072 storage
oscilloscope. The signal was by, and command pulses routed via, a
1401 interface (Cambridge Electronic Design). Signals were filtered
at 1 kHz through a 5-pole Tchebicheff filter, digitized at between 0.1
and 10 kHz using a 1401 interface (Cambridge Electronic Design)
and recorded on the hard drive of an IBM compatible 386 computer.
Voltage and current commands from the amplifier were remotely
controlled from the computer, and analysis performed, using Vclamp
software (Cambridge Electronic Design, version 5).
Fluorescent Calcium Imaging
TEC cultures were grown in the standard medium upon sterile
glass coverslips previously coated with poly-d-lysine (1–10% v/v) for
3 days after passage. Cells were loaded with the ratiometric calcium
indicator fura-2 either by incubation for 15–60 min, at 37 °C with
1–10 ÌM of the AM ester of fura-2 after being washed in serum-free
medium, or by a 30-min incubation with liposomes (composed of
phosphatidylserine, phosphatidylcholine, and cholesterol in a
2:20:10 ratio) containing fura-free acid or fura-2 dextran conjugate,
both with the zinc chelating compound N,N,N),N)-tetrakis(2-pyri-
dylmethyl)ethylenediamine (TPEN) which was also applied to the
cultures for between 30 min to 2 h prior to liposome application.
After fura-2 incorporation the cultures were washed with modified
Ringer’s solution (140 mM NaCl, 5.4 mM KCl, 1 mM MgCl, 10 mM
CaCl2, 5.6 mM D-glucose and 5 mM HEPES) in which they were
then equilibrated for 10 min. The coverslip was placed in a recording
chamber that was sealed with silicon grease (RS components). The
holding vessel was then placed into a heated stage on the microscope
and maintained at 37°C.
The cells were observed using a Nikon inverting microscope with
a 40! objective. Intracellular calcium changes were monitored with
a dynamic video imaging system (Applied Imaging MagiCal system
Newcastle, UK [32]). Each cell was calibrated at the end of the
recording by application of 10 ÌM calcium ionophore (A23187, Sig-
ma) in modified Ringer’s and in calcium-free Ringer’s (140 mM
NaCl, 5.4 mM KCl, 1 mM MgCl, 10 mM EGTA, 5.6 mM D-glucose
and 5 mM HEPES). Cells which did not produce a swift, reversable
change in fluorescent ratio to the calibration protocol were excluded
from the experiment.
To quantify changes in intracellular calcium in response to pro-
gesterone (1 ÌM ), a control wash with modified Ringer’s solution
only was applied to the recording bath, then the same solution with
added progesterone was applied in excess, after an application of 30 s
to 1 min the compound was washed away by flushing the recording
chamber with the control Ringer.
Immunocytochemistry
TEC cultures were grown in the standard medium for 3 days after
passage upon sterile glass coverslips, previously coated with poly-d-
lysine (1–10% v/v). The cells were fixed in acetone for 2 min and air
dried, after which they could be stored, wrapped in cling film at
–30°C for up to 1 week, being defrosted at room temperature,
unwrapped and air dried before processing. All reagents were made
Fig. 1. Mean B SEM change in thymulin level compared to a prein-
cubation period of similar duration. Supernatant thymulin levels
were determined by ELISA. The known thymulin secretagogue pro-
gesterone (Prog) significantly increased the levels of supernatant thy-
mulin. Co-application of cobalt with progesterone prevented the pro-
gesterone-induced increase in thymulin levels, a significant reduction
compared to the effect of progesterone. Cobalt also reduced basal
secretion (82 B 32%, n = 3) but this change was not significant. * p !
0.05.
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up in phosphate-buffered saline containing 1% Triton X (Sigma). A
solution containing 0.1% casein and 0.1% bovine serum albumin
(both from Sigma) was applied to the cells to block nonspecific bind-
ing. Immunocytochemistry was performed conventionally using op-
timally diluted monoclonal antibodies: 4ß (raised to synthetic thy-
mulin by Mary Ritter, London); AG7 (raised to sperm acrosome
antigen-1 by Cosima Brucker, Munich) and pan-cytokeratin (Sigma).
For negative controls the primary antibody was omitted. The reac-
tion was visualized by enhanced diaminobenzidine and viewed
under bright-field illumination.
Statistics
Data is expressed as mean B SEM, and significance analysed
using Student’s t tests.
Results
Thymulin Determination
Supernatant thymulin levels after 2 h were increased
by 1 ÌM progesterone (fig. 1) to 142 B 16% of the preap-
plication period (p ! 0.02, n = 3). This increase was not
seen in the presence of 2.5 mM cobalt chloride (82 B 15%
of controls, n = 3). Cobalt chloride alone caused a slight,
but not significant, reduction of thymulin levels (82 B
32% of controls, n = 3).
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Fig. 2. Electrophysiological effects of progesterone. A Application of
progesterone caused a depolarization of the TEC membrane poten-
tial. In this case 1 mM progesterone caused the cell to depolarize
from –55 to +15 mV. Most depolarizations were of a smaller magni-
tude although other depolarizations to positive membrane voltages
were seen. B Application of progesterone induced an inward current.
Here, repeated applications of 1 mM progesterone are shown illus-
trating both the inward current and the desensitization seen. C Depo-
larization of the cell in response to progesterone was dose-dependent.
The mean B SEM change in membrane potential of 5–9 cells in
response to progesterone at 0.1, 1.0 and 10 mM is shown. ** p !
0.01.
Electrophysiology
Progesterone induced membrane depolarizations
(¢Em) and inward currents (¢I) in 56% of TEC (n = 40).
Illustrations of these responses are shown in figure 2A and
B respectively. Responses were desensitizing, a second
sequential application having a lower effect (36 B 12% of
1st application, n = 7, p ! 0.05, pooled Em and I) as shown
in figure 2B. The mean inward current induced by 1 ÌM
progesterone was –24 B 9 pA (n = 7, p ! 0.02). Depolari-
zations of up to 22 mV resulted from the application of
progesterone (mean ¢Em = 7.1 B 1.8 mV at 1 ÌM, n = 19,
p ! 0.01). These sometimes took the cell to positive mem-
brane voltages (fig. 2A). Depolarizations were dose-de-
pendent (100 nM, ¢Em = –1.1 B 1.5 mV; 1 ÌM, ¢Em =
4.6 B 1.3 mV, p ! 0.05; 10 ÌM, ¢Em = 11.9 B 3.7 mV,
p ! 0.05; all n = 7, paired recordings; fig. 2C). The reversal
potential of the current was at +41 B 14 mV (n = 7). In
addition, depolarizing responses became hyperpolarizing
after substitution of extracellular sodium with choline in 5
cells (¢Em = +4 B 1 mV to ¢Em = –5 B 2 mV, n = 5, p !
0.02), implicating sodium as a major permeant ion.
Fluorescent Calcium Imaging
In cells with adequate ionomycin calibration intracel-
lular calcium was increased following application of 1 ÌM
progesterone (n = 10/30, p ! 0.001). The temporal and
spatial response characteristics of a progesterone-evoked
calcium signal are shown in figure 3. The peak intracellu-
Fig. 3. This figure shows the change in nominal intracellular calcium
(y-axis) with time (x-axis) in the cell shown as an inset. The pseudoco-
lour scale within the y-axis shows the relationship between colour
and calcium concentration used to produce the pseudocolour image
of the calcium concentration within the cell (inset) during the
response to 1 ÌM progesterone (frame position is indicated by the
white star). The progesterone application, to wash out the control
ringer, took place during the period marked by the white bar. Proges-
terone caused a rapid, reversible increase in intracellular calcium of
this TEC. Progesterone remained in the chamber until the end of this
recording, after which a response to calcium ionophore was obtained
(not shown).
Fig. 4. Immunoreactivity of TEC, 3 days after passage, for anti-
bodies to AG7 (A), thymulin (B), and cytokeratin (C). The scale is
given by the scale bar in A which represents 10 Ìm. A Immunoreac-
tivity to AG7 was observed in all cells and was distributed fairly
evenly. Small cells and those near the edge of the monolayer were in
general more intensely stained. B Thymulin staining of TEC. All cells
showed a positive reaction. C Cytokeratin was seen in all cells, form-
ing a network through the cell body. Cells at the edges of monolayers
were more intensely stained than those in the centre. Single cells were
invariably darkly stained.
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lar calcium levels were achieved 4–6 min after application
of 1 ÌM progesterone. Changes in intracellular calcium
were not evenly distributed over the cell. The highest lev-
els were seen in some areas of the cell border and in the
nucleus. No changes were seen with vehicle control (29
cells).
Immunocytochemistry
Cultured cells were immunoreactive for cytokeratin,
thymulin and AG7 (fig. 4). No unstained cells were ob-
served with these antibodies. No negative controls were
stained.
Discussion
TEC are potential targets of neuroendocrine ligands
present in the circulation [33–35] and of input from the
thymic innervation [36–39]. Ionic mechanisms of TEC
have previously been implicated in thymulin secretion
[40, 41]. The present study and our previous work show
that TS-TEC possess ligand-induced adrenergic and ste-
roidal mechanisms [42, 43].
Here we demonstrate direct actions of progesterone
upon various physiological responses of TS-TEC. Classi-
cally, progesterone action involves cytoplasmic steroid
receptors that induce changes in DNA transcription.
These receptors are present on TEC and steroid-induced
changes in thymic physiology and thymulin secretion
have mainly been ascribed to genomic action [18, 27].
Some of the progesterone-induced responses previously
demonstrated by us in these cells [30], namely a reduction
in intercellular coupling and an increase in proliferation,
may be partly due to such genomic responses. However,
the electrophysiological changes and calcium flux ini-
tiated by progesterone in this study occur too rapidly to be
genomic effects. The inhibition of progesterone-evoked
secretion by cobalt also suggests that short-term (2 h)
changes in thymulin release are a direct effect of calcium-
dependent exocytosis rather than of increased thymulin
expression.
Both electrophysiological recordings and calcium
imaging suggest that nongenomic responses may not oc-
cur in all cells. This could be a reflection of the morpho-
logical heterogeneity of the cultures [30] and their vari-
able expression of ion channels [44].
Electrophysiological responses of TEC were observed
in response to the application of progesterone. These
responses comprised the activation of transmembrane
currents and changes in transmembrane voltages that
were desensitizing and dose-dependent. These changes
were consistent with the activation of a poorly selective
cation current. This is a novel action of progesterone in
somatic cells. It is not consistent with established actions,
whereby progesterone and/or its metabolites increase and
prolong the Á-aminobutyric acid-A chloride current [45]
or inhibit cation currents stimulated by cholinergic ago-
nists at nicotinic acetylcholine receptors [46].
Poorly selective cation currents activated by progester-
one have also been reported in sperm which result in an
influx of sodium and calcium activating the acrosome
reaction [47]. A membrane-bound receptor initiating a
nongenomic signal transduction pathway has been impli-
cated in this effect. The membrane-bound sperm acro-
some antigen-1 (SAA-1), that is internalized after proges-
terone binding, forms part of this pathway [48]. SAA-1 is
recognized and inhibited by the antibody AG7 [1]. SAA-1
could be a progesterone receptor, a separate ion channel
or an accessory protein [48]. The positive immunoreactiv-
ity to AG7 suggests that a similar mechanism may be
present in TS-TEC. Furthermore, the characteristics of
the current induced in sperm by progesterone are compa-
rable to those seen in TEC, and both result in rapid cal-
cium influx.
The nongenomic progesterone receptor in TS-TEC has
not yet been characterized and no details of its structure
or molecular weight are known. Functionally we have
demonstrated that in TS-TEC, activation of this proges-
terone receptor leads to ion channel activation. Although
progesterone membrane-binding proteins have been
found in a number of cell types [26], none of them have
been shown to activate ion channels. Three hypothetical
mechanisms, whereby the progesterone receptor of TEC
may open an ion channel, are presented in figure 5. First-
ly, the receptor may be metabotropic, coupling to a sepa-
rate ion channel via second messengers (fig. 5A). Sec-
ondly, the receptor may be a membrane-bound protein
that aggregates as a subunit or component of an ion chan-
nel (fig. 5B). Thirdly, the receptor may incorporate an ion
channel, allowing it to be directly ionotropic (fig. 5C).
Any of these models may allow calcium influx through the
channel, although in such nonselective cation channel the
proportion of calcium is likely to form only a small pro-
portion of the current. The large calcium influx seen sug-
gests the presence of voltage-gated calcium channels that
open in response to the progesterone-induced depolariza-
tion. This hypothesis is supported by the inhibition of
secretion seen with cobalt.
A functional consequence of an influx of calcium is the
secretion of thymulin [40, 41]. Thus calcium influx could
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Fig. 5. Models of nongenomic progesterone
signal transduction in TS-TEC. A Progester-
one binds to a novel membrane-bound re-
ceptor which activates an ion channel via
second messengers. B Progesterone binds to
a novel membrane-bound receptor which ac-
tivates an ion channel by associating with
the ion channel molecule. C Progesterone
binds to a novel ionotropic receptor. D Al-
though calcium influx may occur through
the initial channel (A) it may be augmented
through cell depolarization and the subse-
quent opening of voltage-dependent calcium
channels. Additional signals initiated by pro-
gesterone are mediated by cytoplasmic re-
ceptors and genomic action.
explain the rapid progesterone-mediated secretion of thy-
mulin through non-genomic pathways. These are in addi-
tion to the documented long-term effects of progesterone
upon thymulin synthesis and cell proliferation [27, 30].
Conclusions
The thymus, as one of the primary lymphoid organs,
plays a crucial role in immunological defence and its out-
put can be altered by neural and endocrine stimuli. These
stimuli can act upon immature thymocytes but also affect
the stromal cells of the gland which create the thymic
microenvironment and provide developmental cues for
the thymocytes.
The stromal cells of the thymus do not appear to be a
static, structural framework, carrying out predetermined
steps in thymocyte differentiation. The results of this and
our previous studies show that TS-TEC form a plastic net-
work that is highly responsive to a wide range of inflam-
matory, neuroendocrine and neural signals.
The range of ligands to which these cells respond sug-
gest that ligands have coordinate actions upon these cells.
The large number of inputs may suggest that TS-TEC are
involved in signal recognition and processing for the
thymic-immune axis.
This paper confirms progesterone to be one of the fac-
tors capable of stimulating TS-TEC to modulate aspects
of their physiology. The ligand-induced responses of TS-
TEC are diverse. Progesterone acting through a combina-
tion of genomic and nongenomic actions influences pro-
liferation, secretion, the degree of communication be-
tween epithelial cells and hence modulates interactions
with thymocytes.
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